Search Clinical Trials
Before medications are approved by the U.S. Food and Drug Administration (FDA) or before certain therapy methods are widely accepted as effective, they are tested on people who volunteer to participate in a clinical trial.
Organizations across the country are looking for people like you to take part in their research studies. The list of studies below have been selected from ClinicalTrials.gov based on their inclusion of one or more of the following terms: anxiety disorders, depression, OCD, PTSD, and bipolar disorder.
The Anxiety and Depression Association of America (ADAA) is supportive of research that is conducted through clinical trials. Participating in research can potentially help change the mental health outcomes for you and others who suffer anxiety, depression, and related disorders. You may learn about new interventions/treatments that are being considered.
Read this ADAA blog about things to know and questions to ask before committing to a clinical trial.
This website page is brought to you in partnership with ResearchMatch.
Sponsor Condition of Interest |
---|
Aβ Dynamics in LLMD
NYU Langone Health
Alzheimer Disease
Major Depressive Disorder
This study will examine the biological factors that may modulate the relationship between
depression and the development of Alzheimer's disease (AD). Since the direction of
causation between depression and the biological factors associated with AD is unknown,
the only way to understand cause and as1 expand
This study will examine the biological factors that may modulate the relationship between depression and the development of Alzheimer's disease (AD). Since the direction of causation between depression and the biological factors associated with AD is unknown, the only way to understand cause and associated risk is to treat the depressive symptoms and examine the effects on AD biomarkers. The study involves an FDA-approved treatment for major depressive disorder. It will compare the SSRI antidepressant escitalopram with placebo. The hypothesis is that a reduction in depressive symptoms will be associated with a normalization of CSF AD biomarkers as well as peripheral inflammatory markers. This research would contribute to fundamental knowledge about potentially modifiable risks of Alzheimer's disease (AD). Type: Interventional Start Date: Feb 2022 |
Academic-Community EPINET (AC-EPINET)
Indiana University
Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorders
Major Depression with Psychotic Features
Bipolar Disorder with Psychotic Features
The investigators propose to examine the effects of CSC services delivered via TH
(CSC-TH) versus the standard clinic-based CSC model (CSC-SD) on engagement and outcomes
in a 12-month, randomized trial. expand
The investigators propose to examine the effects of CSC services delivered via TH (CSC-TH) versus the standard clinic-based CSC model (CSC-SD) on engagement and outcomes in a 12-month, randomized trial. Type: Interventional Start Date: Mar 2022 |
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
University of Cincinnati
Anxious Depression
Depression
Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram,
followed by double-blind, randomized adjunctive treatment with clonazepam or pregabalin
for persistent symptoms. expand
Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram, followed by double-blind, randomized adjunctive treatment with clonazepam or pregabalin for persistent symptoms. Type: Interventional Start Date: Mar 2020 |
rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression
Indiana University
Depression, Treatment Resistant
The goal of this clinical trial is to learn if Transcranial Magnetic Stimulation (TMS) to
part of the brain called the ventromedial prefrontal cortex (VMPFC) can treat a symptom
called rumination in adults with major depression that has not responded to at least one
medication trial. The main quest1 expand
The goal of this clinical trial is to learn if Transcranial Magnetic Stimulation (TMS) to part of the brain called the ventromedial prefrontal cortex (VMPFC) can treat a symptom called rumination in adults with major depression that has not responded to at least one medication trial. The main question it aims to answer are: Does TMS to the VMPFC change brain activity on functional magnetic resonance imaging (fMRI) during a negative self-referential processing task in adults with depression? Does TMS to the VMPFC affect rumination in adults with depression? Researchers will compare brain scans and rumination scores before, during, and immediately after TMS. Participants will: Undergo three functional MRI scans Undergo a course of 20 TMS treatments Respond to clinical questionnaires and complete a computer behavioral task Type: Interventional Start Date: Jan 2024 |
Accelerated rTMS for Substance Use Disorder and Depression
University of Texas Southwestern Medical Center
Stimulant Use
Depression
This study is a small open-label feasibility trial of an accelerated course of repetitive
transcranial magnetic stimulation (rTMS) for individuals with depression and stimulant
use disorder [including methamphetamine or cocaine use disorder (MUD/CUD)]. expand
This study is a small open-label feasibility trial of an accelerated course of repetitive transcranial magnetic stimulation (rTMS) for individuals with depression and stimulant use disorder [including methamphetamine or cocaine use disorder (MUD/CUD)]. Type: Interventional Start Date: Jun 2024 |
Reducing Mental Health Disparities Among Latinxs With a Telenovela Intervention
University of Nevada, Reno
Anxiety Disorders
The primary aim of our study is to determine the effectiveness of an transdiagnostic
telenovela video intervention in reducing anxiety and depressive symptoms using a
pre/post-test design with Spanish-speaking Latinxs. expand
The primary aim of our study is to determine the effectiveness of an transdiagnostic telenovela video intervention in reducing anxiety and depressive symptoms using a pre/post-test design with Spanish-speaking Latinxs. Type: Interventional Start Date: Jul 2024 |
Music-Based Interventions, Aging, Alzheimer's Disease
University of Southern California
Speech Perception
Anxiety
Social Behavior
Using a randomized controlled trial design, the investigators will examine the effects of
music engagement through choir training on the hearing, communication, and psychosocial
well-being of older adults, particularly those at heightened risk of developing dementia. expand
Using a randomized controlled trial design, the investigators will examine the effects of music engagement through choir training on the hearing, communication, and psychosocial well-being of older adults, particularly those at heightened risk of developing dementia. Type: Interventional Start Date: Oct 2024 |
Psychotherapy Effects on Reward Processing in PTSD
University of Texas at Austin
Post Traumatic Stress Disorder
Diminished Pleasure
Anhedonia
PTSD
Chronic PTSD
The purpose of this study is to identify how trauma-focused psychotherapy changes the
function of brain circuitry in posttraumatic stress disorder (PTSD) and how this mediates
improvements in the diminished ability to experience positive emotions following a
traumatic or extremely stressful life ev1 expand
The purpose of this study is to identify how trauma-focused psychotherapy changes the function of brain circuitry in posttraumatic stress disorder (PTSD) and how this mediates improvements in the diminished ability to experience positive emotions following a traumatic or extremely stressful life event. In this instance, the investigators will be using cognitive processing therapy (CPT), a widely-utilized and evidence-based treatment for PTSD. Type: Interventional Start Date: Jun 2024 |
Cancer Pain Management Using a Web-based Intervention
University of Texas at Austin
Cancer of Breast
Depressive Symptoms
Cancer Pain
This study is funded by the HEAL Initiative (https://heal.nih.gov/). Based on Preliminary
Studies (PSs), the research team developed and pilot-tested an evidence-based Web
App-based information and coaching/support program for cancer pain management (CAPA) that
was culturally tailored to Asian Amer1 expand
This study is funded by the HEAL Initiative (https://heal.nih.gov/). Based on Preliminary Studies (PSs), the research team developed and pilot-tested an evidence-based Web App-based information and coaching/support program for cancer pain management (CAPA) that was culturally tailored to Asian American breast cancer survivors using multiple unique features. However, CAPA rarely considered depressive symptoms accompanying pain in its design or components, and PSs indicated the necessity of further individualization of the intervention components of CAPA due to diversities in the needs of ABD. The purpose of the proposed 2-phase study is to further develop CAPA with additional components for ABD and the individual optimization functionality (CAI) and to test the efficacy of CAI in improving cancer pain experience of ABD. The specific aims are to: a) develop and evaluate CAI through an expert review and a usability test (R61 phase); b) determine whether the intervention group (that uses CAI and usual care) will show significantly greater improvements than the active control group (that uses CAPA and usual care) in primary outcomes (cancer pain management and cancer pain experience including depressive symptoms) from baseline to post 1-month and post 3-months; c) identify theory-based variables (attitudes, self-efficacy, perceived barriers, and social influences) that mediate the intervention effects of CAI on the primary outcomes; and d) determine whether the effects of CAI on the primary outcomes are moderated by selected background, disease, genetic, and situational factors. This study is guided by the Bandura's Theory and the stress and coping framework by Lazarus and Folkman. The R61 phase includes: (a) the intervention development process, (b) a usability test among 15 ABD, 15 family members, and 15 community gatekeepers; and (c) an expert review among 10 experts in oncology. The R33 phase adopts a randomized repeated measures control group design among 300 ABD. Long-term goals are: (a) to extend and test CAI in various healthcare settings with diverse subgroups of ABD, (b) examine the costeffectiveness, sustainability, and scalability of CAI in the settings, and (c) translate CAI into health care for ABD. Type: Interventional Start Date: Feb 2024 |
Intervention to Reduce Safety Behaviors
VA Office of Research and Development
Social Anxiety
Social anxiety is associated with significant deficits in social and occupational
functioning. The proposed study seeks to evaluate the feasibility of implementing a brief
text-based intervention for decreasing social anxiety related safety behaviors among
Veterans attempting to re-integrate into t1 expand
Social anxiety is associated with significant deficits in social and occupational functioning. The proposed study seeks to evaluate the feasibility of implementing a brief text-based intervention for decreasing social anxiety related safety behaviors among Veterans attempting to re-integrate into the workforce. Findings from this pilot will support a larger randomized controlled study examining the efficacy of the intervention for improving functional outcomes and quality of life among Veterans. Type: Interventional Start Date: Jul 2024 |
5-HTP and Creatine for Depression R33 Phase
University of Utah
Major Depressive Disorder
This is a three-armed clinical trial examining the effect of 5-hydroxytryptophan and
creatine monohydrate as augmenting agents for the treatment of depression. Subjects will
be randomized between 5-HTP 100mg BID + creatine 5g daily, 5-HTP 200mg BID + creatine 10g
daily, vs double placebo, for 8 wee1 expand
This is a three-armed clinical trial examining the effect of 5-hydroxytryptophan and creatine monohydrate as augmenting agents for the treatment of depression. Subjects will be randomized between 5-HTP 100mg BID + creatine 5g daily, 5-HTP 200mg BID + creatine 10g daily, vs double placebo, for 8 weeks. The ability of the interventions to affect biomarkers associated with depression will be assessed using brain phosphorus magnetic resonance spectroscopy, functional connectivity imaging, and plasma serotonin levels. Type: Interventional Start Date: Sep 2023 |
taVNS or TMS or Both for Depression
Medical University of South Carolina
Depression
The purpose of the research is to test out a combined treatment for depression where the
investigators stimulate a nerve in the ear while at the same time stimulate the brain
with magnets. These treatments are called transcutaneous (through the skin) auricular
(ear) vagus nerve stimulation (taVNS)1 expand
The purpose of the research is to test out a combined treatment for depression where the investigators stimulate a nerve in the ear while at the same time stimulate the brain with magnets. These treatments are called transcutaneous (through the skin) auricular (ear) vagus nerve stimulation (taVNS) and transcranial (through the skull) magnetic stimulation (TMS). For participants who already have a cervical VNS device, the investigators will not change their treatment and will use this in place of the taVNS. The investigators think this combined method might treat depressive symptoms better than either alone. This study is in person at the Institute of Psychiatry in downtown Charleston on the MUSC campus. First, participants will have a screening session and then will have 6 treatment days total where participants will receive either VNS treatment alone, TMS treatment alone, or both at the same time. The treatment that participants start with will be randomized, and they will have 2 treatment days of each combination. Type: Interventional Start Date: Mar 2023 |
Decoding and Modulating Affective Brain States
University of Pennsylvania
Rumination
Major Depressive Disorder
Anxiety
Generating personalized brain signatures of negative emotion along with personalized
brain stimulation protocols to disrupt these patterns. We plan to use fMRI and muscle
activity data to determine negative affect maps for each participant. We will then try a
variety of patterned repetitive transcr1 expand
Generating personalized brain signatures of negative emotion along with personalized brain stimulation protocols to disrupt these patterns. We plan to use fMRI and muscle activity data to determine negative affect maps for each participant. We will then try a variety of patterned repetitive transcranial magnetic stimulation sequences while recording fMRI which will be the basis of two sessions of 3-day individualized brain stimulation designed to reduce negative affect. Type: Interventional Start Date: Feb 2023 |
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatmen1
University of Alabama at Birmingham
Major Depressive Disorder
Suicidal Ideas
Suicide, Attempted
MDD
Depression
This study is dedicated to help identify biomarkers for depression and suicide. The
purpose of the study is to better understand these links to improve medical and
psychiatric care in the future. This research is also to test the effects of standard
treatment of depression on improvement in depress1 expand
This study is dedicated to help identify biomarkers for depression and suicide. The purpose of the study is to better understand these links to improve medical and psychiatric care in the future. This research is also to test the effects of standard treatment of depression on improvement in depressive and suicidal behavior and on biomarkers (e.g. miRNA) for these disorders. Type: Interventional Start Date: Oct 2022 |
Treatments for Insomnia in Veterans With PTSD
VA Office of Research and Development
Insomnia
PTSD
This randomized trial will compare a novel treatment, Acceptance of the Behavioral
Changes to Treat Insomnia (ABC-I) to Cognitive Behavioral Therapy for Insomnia (CBT-I)
among Veterans with comorbid Post-Traumatic Stress Disorder (PTSD) and insomnia disorder.
ABC-I combines the behavioral component1 expand
This randomized trial will compare a novel treatment, Acceptance of the Behavioral Changes to Treat Insomnia (ABC-I) to Cognitive Behavioral Therapy for Insomnia (CBT-I) among Veterans with comorbid Post-Traumatic Stress Disorder (PTSD) and insomnia disorder. ABC-I combines the behavioral components of CBT-I with components of another behavioral therapy (Acceptance and Commitment Therapy) and has been shown to improve treatment adherence. The study objectives are: 1) to evaluate the benefits of ABC-I in reducing post-traumatic stress disorder (PTSD) symptoms among Veterans with comorbid PTSD and insomnia disorder compared to CBT-I, and 2) to evaluate the effectiveness of ABC-I in improving insomnia symptoms and sleep quality among Veterans with comorbid PTSD and insomnia disorder as compared to CBT-I. Veterans with insomnia and comorbid PTSD who receive care at Sepulveda and West Los Angeles facilities will be recruited for the study. Those who pass an initial eligibility screen will be enrolled and written informed consent will be obtained. A baseline assessment will be completed that includes measures of sleep, PTSD, and quality of life. Veterans who meet all eligibility criteria will be randomly assigned to the ABC-I (n=100) or CBT-I (n=100) treatment. Both treatments will be provided in 5 one-on-one sessions by a trained instructor who is supervised by a behavioral sleep medicine specialist. All randomized participants (n=200) will have 3 follow-up assessments (post-treatment, 3-months, and 6-months after randomization). The follow-up assessments will collect information on PTSD symptoms, insomnia symptoms and sleep quality. Type: Interventional Start Date: Sep 2022 |
Weighted Blanket to Treat Anxiety Related to Trying New Foods the Pediatric Population
The University of Texas Medical Branch, Galveston
Food Neophobia
Picky Eating
Avoidant Restrictive Food Intake Disorder
Anxiety State
This small experimental pilot study addresses the knowledge gap related to the use of
weighted blankets for children with anxiety related to food and eating. expand
This small experimental pilot study addresses the knowledge gap related to the use of weighted blankets for children with anxiety related to food and eating. Type: Interventional Start Date: Jun 2024 |
PD, PK, and Safety of ALTO-203 in Patients With MDD
Alto Neuroscience
Major Depressive Disorder
Anhedonia
The goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203
in patients with MDD in a randomized, placebo-controlled, single-dose crossover treatment
period. Additionally, safety, tolerability, and PK will be assessed in a subsequent
randomized placebo-controlled multi-d1 expand
The goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203 in patients with MDD in a randomized, placebo-controlled, single-dose crossover treatment period. Additionally, safety, tolerability, and PK will be assessed in a subsequent randomized placebo-controlled multi-dose parallel-group treatment period of 28 days. Participants will complete subjective response questionnaires and perform cognitive tasks during the single-dose period, in which participants will receive ALTO-203 25 μg and 75 μg, as well as placebo. During the multiple-dose period, participants will receive either ALTO-203 25 μg, 75 μg , or placebo. Safety will be assessed over the single dose and 28-day multiple dose periods. Type: Interventional Start Date: Mar 2024 |
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED
University of Oklahoma
Laceration of Skin
Anxiety
Discharge Time
Pain in young children has been universally under-recognized due to their inability to
describe or localize pain. Improvements in pharmacological interventions are necessary to
optimize patient and family experience and allow for successful and efficient procedure
completion. This is the first stud1 expand
Pain in young children has been universally under-recognized due to their inability to describe or localize pain. Improvements in pharmacological interventions are necessary to optimize patient and family experience and allow for successful and efficient procedure completion. This is the first study that will compare three intranasal medications (Intranasal Midazolam, Dexmedetomidine, and Ketamine) to evaluate the length of stay after medication administration along with patient and provider satisfaction. The objective of this study is to demonstrate superior intranasal anxiolysis for pediatric laceration repairs with the shortest emergency department stay and highest patient and provider satisfaction. Based on previous studies and medication pharmacokinetics, we hypothesize that Intranasal Ketamine will have the shortest Emergency Department (ED) stay followed by Midazolam and then Dexmedetomidine with the longest stay; however, Dexmedetomidine will have the highest patient and provider satisfaction followed by Ketamine and then Midazolam. Type: Interventional Start Date: Nov 2023 |
Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part1
Brigham and Women's Hospital
Depression
Anxiety Disorders
This study is a clinical trial that evaluates what drives patient engagement and tests
the impact of two strategies-automated motivational push messaging and coach support-to
improve engagement with an evidence-based mobile app intervention for depression and/or
anxiety. expand
This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to improve engagement with an evidence-based mobile app intervention for depression and/or anxiety. Type: Interventional Start Date: Jun 2023 |
Mechanisms of Rumination Change in Adolescent Depression
Ohio State University
Major Depressive Disorder
Mood Disorders
This study will evaluate whether a newer treatment, rumination-focused cognitive
behavioral treatment, which includes mindfulness and can be used to reduce ruminative
habits, change ways in which key brain regions interact with each other (e.g.., often
called connectivity), and whether these change1 expand
This study will evaluate whether a newer treatment, rumination-focused cognitive behavioral treatment, which includes mindfulness and can be used to reduce ruminative habits, change ways in which key brain regions interact with each other (e.g.., often called connectivity), and whether these changes in habits and brain connectivity can reduce the risk for recurrence of depression in the next two years. Type: Interventional Start Date: May 2019 |
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
Massachusetts General Hospital
Anxiety Disorders
Psychotic Disorders
Depressive Disorder
Psychosocial Functioning
This research study aims to develop a brief group-based treatment called Resilience
Training for Teens, then to test how well it protects high school students with mild
symptoms of depression, anxiety, or having unusual feelings from developing mental
illnesses. expand
This research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses. Type: Interventional Start Date: Mar 2024 |
Antidepressant Effects of Nitrous Oxide
University of Chicago
Major Depressive Disorder
Treatment Resistant Depression
To evaluate the acute and sustained antidepressant effects of nitrous oxide in people
with major depressive disorder; and further evaluate these effects by identifying the
optimal dose and regimen to guide current practice, and to plan a future large pragmatic
trial. expand
To evaluate the acute and sustained antidepressant effects of nitrous oxide in people with major depressive disorder; and further evaluate these effects by identifying the optimal dose and regimen to guide current practice, and to plan a future large pragmatic trial. Type: Interventional Start Date: Jun 2021 |
Pilot Study of Virtual Reality Therapy for Students With Anxiety
The University of Texas Health Science Center, Houston
Anxiety
The purpose of this study is to assess changes in self-reported anxiety over the course
of six virtual reality (VR) sessions and to assess changes in academic self-efficacy, as
well as examine the feasibility and acceptability of a relatively short and time
intensive VR intervention (i.e.,six sessi1 expand
The purpose of this study is to assess changes in self-reported anxiety over the course of six virtual reality (VR) sessions and to assess changes in academic self-efficacy, as well as examine the feasibility and acceptability of a relatively short and time intensive VR intervention (i.e.,six sessions over the course of three weeks) for reducing anxiety symptoms in college students. Type: Interventional Start Date: Apr 2022 |
Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans
University of Illinois at Chicago
Chronic Pain
Acute Pain
Fatigue
Depression
This research study is being done to investigate if the GH Method exercise program
positively affects body composition, improves physical abilities and can improve the
overall sense of wellbeing (e.g. depression, PTSD, etc.) in U.S. Veterans. Subjects will
be asked to complete 94 total visits (four1 expand
This research study is being done to investigate if the GH Method exercise program positively affects body composition, improves physical abilities and can improve the overall sense of wellbeing (e.g. depression, PTSD, etc.) in U.S. Veterans. Subjects will be asked to complete 94 total visits (four (4) study testing visits and 90 exercise visits). Enrolled subjects will be tested for fitness, strength, and health risk factors at UIC 4 times and will complete 90 exercise training visits at the GH FITLab over the next 18 months. Subjects will also be asked to complete questionnaires about depression, post-traumatic stress symptoms and thoughts about harming oneself. Type: Interventional Start Date: Oct 2021 |
Behavioral Activation-Rehabilitation to Improve Depressive Symptoms & Physical Function After Acute1
Johns Hopkins University
Respiratory Insufficiency
Depression
Rehabilitation
Critical Care
More and more people are surviving after receiving life support for respiratory failure
in the intensive care unit, but these patients often experience problems with depression
and physical functioning that lead to reduced quality of life. There is a lack of
treatment for these patients, with past1 expand
More and more people are surviving after receiving life support for respiratory failure in the intensive care unit, but these patients often experience problems with depression and physical functioning that lead to reduced quality of life. There is a lack of treatment for these patients, with past research suggesting that treatment may be more successful if mental and physical health are addressed at the same time. This research evaluates whether a therapy delivered via telephone and home visits, combining treatment for depression and physical rehabilitation, is feasible and might help patients recover. Type: Interventional Start Date: Mar 2018 |
- Previous
- Next